We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

106 hedge funds and large institutions have $13.5M invested in Sanofi Contingent Value Rights in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $12.6M → $13.5M (+$914K)

7% less funds holding

Funds holding: 114 → 106 (-8)

22% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 18

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

Holders
106
Holders Change
-8
Holders Change %
-7.02%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
8
Increased
14
Reduced
18
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$581K
2
MFP
Michael F. Price
+$205K
3
CL
CSS LLC
Illinois
+$84K
4
TL
TowerView LLC
New York
+$32.3K
5
FCM
Farallon Capital Management
California
+$27K

Top Sellers

Rank Fund Capital Flow
1
SAM
Silverback Asset Management
North Carolina
-$97K
2
ACM
Akanthos Capital Management
California
-$75K
3
Citadel Advisors
Citadel Advisors
Florida
-$31K
4
PC
Permanens Capital
New York
-$13K
5
ZIG
Zuckerman Investment Group
Illinois
-$6.16K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIA
51
Biondo Investment Advisors
Pennsylvania
$2K -$35 -325 -2%
HK
52
Horizon Kinetics
New York
$2K – – –
MC
53
Moors & Cabot
Massachusetts
$2K – – –
BlackRock
54
BlackRock
New York
$1K – – –
DA
55
Dillon & Associates
Michigan
$1K – – –
RL
56
Ruffer LLP
United Kingdom
$1K – – –
RJA
57
Raymond James & Associates
Florida
$1K +$1.23K +11,384 New
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
$600 -$591 -5,455 -50%
SIM
59
Sonora Investment Management
Arizona
$292 +$67 +614 +38%
WEC
60
Winslow Evans & Crocker
Massachusetts
$157 – – –
SWA
61
Sutton Wealth Advisors
Florida
$38 +$36 +336 New
MPWT
62
MassMutual Private Wealth & Trust
Connecticut
$5 +$3 +30 +214%
ECM
63
Estabrook Capital Management
New York
$2 – – –
SAM
64
Silverback Asset Management
North Carolina
– -$97K -861,200 Closed
ACM
65
Akanthos Capital Management
California
– -$75K -667,000 Closed
Citadel Advisors
66
Citadel Advisors
Florida
– -$31K -271,701 Closed
PC
67
Permanens Capital
New York
– -$13K -112,982 Closed
KAM
68
Kazazian Asset Management
Florida
– -$6K -49,328 Closed
DBG
69
De Burlo Group
Massachusetts
– -$4K -39,800 Closed
WC
70
Whitney & Co
New York
– -$4K -31,885 Closed
TSS
71
Two Sigma Securities
New York
– -$2K -18,556 Closed
ACS
72
Archford Capital Strategies
Illinois
– -$1K -680 Closed
Creative Planning
73
Creative Planning
Kansas
– -$44 -402 -13%
WTC
74
WhitTier Trust Company
Nevada
– -$27 -250 -11%
CTC
75
Central Trust Company
Missouri
– -$10 -95 -2%
1 2
3
4

GCVRZ Hedge Fund Activity: Q1 2016 in Review

106 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2016, worth a combined $13.5M — up 7.2% from $12.6M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 8 opened new positions — a net loss of 8 holders — while 18 trimmed existing stakes and 14 added.

The largest buyer was Stonehill Capital Management, adding an estimated $581K. The largest seller was Silverback Asset Management, exiting entirely with an estimated $97K sold.

  • 106 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2016, down from 114 in Q4 2015.
  • Funds reported $13.5M of Sanofi Contingent Value Rights stock for Q1 2016, up 7.2% quarter-over-quarter.
  • 8 funds opened new Sanofi Contingent Value Rights positions in Q1 2016 and 16 closed out, a net change of -8 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2016 was Stonehill Capital Management, an estimated $581K added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2016 was Silverback Asset Management, an estimated $97K sold.

Based on aggregated 13F filings for Q1 2016.